The use of phage-displayed peptide libraries to develop tumor-targeting drugs

International Journal of Peptide Research and Therapeutics

Volumn 12, Issue 1, 2006, Pages 79-91

  Krumpe, Lauren R H ^a   Mori, Toshiyuki ^b,c  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Biopanning; Cancer; Drug; Filamentous phage; Homing; Imaging; Library; Lytic phage; M13; Nanotechnology; Peptide; Phage display; T7; Targeting; Tumor

Indexed keywords

ALANYLPROLYLARGINYLPROLYLGLYCINE; ARGINYLGLYCYLASPARTIC ACID; ASPARAGINYLGLYCYLARGININE; CYCLOPEPTIDE; CYSTEINYLASPARTYLTHREONYLARGINYLLYSINE; CYSTEINYLGLYCYLLYSYLARGINYLLYSINE; CYSTEINYLPROLYLGLYCYLPROLYLGLUTAMYLGLYCYLALANYLGLYCYLCYSTEINE; DOXORUBICIN; FLUORESCEIN; HISTIDYLTRYPTOPHYLGLYCYLPHENYLALANINE; INTERLEUKIN 11 RECEPTOR; LIPOSOME; LYSYLLEUCYLALANYLLYSYLLEUCYLALANYLLYSYLLYSYLLEUCYLALANYLLYCYLLEUCYLALANYLLY SINE; MONOCLONAL ANTIBODY; PEPTIDE DERIVATIVE; PEPTIDE DUP1; PEPTIDE LIBRARY; PEPTIDE LYP1; PEPTIDE MG11; PEPTIDE PA1; SERYLMETHIONYLSERYLISOLEUCYLALANYLARGINYLLEUCINE; UNCLASSIFIED DRUG;

BACTERIOPHAGE M13; BACTERIOPHAGE T7; CANCER; CANCER MODEL; COMBINATORIAL LIBRARY; DRUG BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ISOLATION; DRUG SCREENING; DRUG TARGETING; HUMAN; ISOTOPE LABELING; MOLECULAR SIZE; NANOPARTICLE; NANOTECHNOLOGY; NONHUMAN; PHAGE DISPLAY; REVIEW;

EID: 33645466758     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-005-9002-3     Document Type: Review

References (90)

1. Adams, G. P. and Weiner, L. M.: 2005. Nat. Biotechnol. 23, 1147-1157.
2. Adams, G. P., Schier, R., McCall, A. M., et al.: 2001, Cancer Res. 61, 4750-4755.
3. Adermann, K., John, H., Standker, L. and Forssmann, W. G.: 2004, Curr. Opin. Biotechnol. 15, 599-606.
4. Adessi, C. and Soto, C.: 2002, Curr. Med. Chem. 9, 963-78.
5. Aina, O. H., Marik, J., Liu, R., Lau, D. H. and Lam, K. S.: 2005, Mol. Cancer Ther. 4, 806-813.
6. Aina, O. H., Sroka, T. C., Chen, M. L. and Lam, K. S.: 2002, Biopolymers 66, 184-199.
7. Akerman, M. E., Chan, W. C., Laakkonen, P., Bhatia, S. N. and Ruoslahti, E.: 2002, Proc. Natl. Acad. Sci. U.S.A. 99, 12,617-12,621.
8. Arap, W., Haedicke, W., Bernasconi, M., et al.: 2002a, Proc. Natl. Acad. Sci. U.S.A. 99, 1527-1531.
9. Arap, W., Kolonin, M. G., Trepel, M., et al.: 2002b, Nat. Med. 8, 121-127.
10. Arap, W., Pasqualini, R. and Ruoslahti, E.: 1998, Science 279, 377-380.
11. Azzazy, H. M. and Highsmith, W. E. Jr.: 2002, Clin. Biochem. 35, 425-445.
12. Barbas, III C. F., Burton, D. R., Scott, J. K. and Silverman, G. J.: 2001, Phage Display: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
13. Bray, B. L.: 2003, Nat. Rev. Drug Discov. 2, 587-593.
14. Castagnoli, L., Zucconi, A., Quondam, M., et al.: 2001, Comb. Chem. High Throughput Screen 4, 121-133.
15. Clackson, T. and Lowman, H. B.: 2004, Phage Display - A Practical Approach, Oxford University Press, New York.
16. Cortez-Retamozo, V., Backmann, N., Senter, P. D., et al.: 2004, Cancer Res. 64, 2853-2857.
17. Deshayes, K., Schaffer, M. L., Skelton, N. J., et al.: 2002, Chem. Biol. 9, 495-505.
18. Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A. and Kim, P. S.: 1999, Cell 99, 103-115.
19. Eichler, J., Appel, J. R., Blondelle, S. E., et al.: 1995, Med. Res. Rev. 15, 481-496.
20. Ellerby, H. M., Arap, W., Ellerby, L. M., et al.: 1999, Nat. Med. 5, 1032-1038.
21. Essler, M. and Ruoslahti, E.: 2002, Proc. Natl. Acad. Sci. U.S.A. 99, 2252-2257.
22. Ferrari, M.: 2005, Nat. Rev. Cancer. 5, 161-171.
23. Fleming, T. J., Sachdeva, M., Delic, M., et al.: 2005, J. Mol. Recognit. 18, 94-102.
24. Grifman, M., Trepel, M., Speece, P., et al.: 2001, Mol. Ther. 3, 964-975.
25. Haubner, R. and Wester, H. J.: 2004, Curr. Pharm. Des. 10, 1439-1455.
26. Ho, I. A., Lam, P. Y. and Hui, K. M.: 2004, Hum. Gene Ther. 15, 719-732.
27. Hoffman, J. A., Giraudo, E., Singh, M., et al.: 2003, Cancer Cell. 5, 383-391.
28. Holig, P., Bach, M., Volkel, T., et al.: 2004, Protein Eng. Des. Sel. 17, 433-441.
29. Huang, C., Liu, X. Y., Rehemtulla, A. and Lawrence, T. S.: 2005, Int. J. Radiat. Oncol. Biol. Phys. 62, 1497-1503.
30. Jiang, T., Olson, E. S., Nguyen, Q. T., et al.: 2004, Proc. Natl. Acad. Sci. U.S.A. 101, 17,867-17,872.
31. Joyce, J. A., Laakkonen, P., Bernasconi, M., Bergers, G., Ruoslahti, E. and Hanahan, D.: 2003, Cancer Cell 4, 393-403.
32. Kay, B. K., Kurakin, A. V. and Hyde-DeRuyscher, R.: 1998, Drug Discov. Today 3, 370-378.
33. Kay, B. K., Kasanov, J. and Yamabhai, M.: 2001, Methods 24, 240-246.
34. Kayushin, A. L., Korosteleva, M. D., Miroshnikov, A. I., et al.: 1996, Nucleic Acids Res. 24, 3748-3755.
35. Kelly, K. A., Allport, J. R., Tsourkas, A., et al.: 2005, Circ. Res. 96, 327-336.
36. Kemp, P., Garcia, L. R. and Molineux, I. J.: 2005, Virology 340, 307-317.
37. Kieber-Emmons, T., Murali, R. and Greene, M. I.: 1997, Curr. Opin. Biotechnol. 8, 435-441.
38. Kolonin, M., Pasqualini, R. and Arap, W.: 2001, Curr. Opin. Chem. Biol. 5, 308-313.
39. Krag, D. N., Fuller, S. P., Oligino, L., et al.: 2002, Cancer Chemother. Pharmacol. 50, 325-332.
40. Kuhnast, B., Bodenstein, C., Haubner, R., et al.: 2004, Nucl. Med. Biol. 31, 337-344.
41. Laakkonen, P., Akerman, M. E., Biliran, H., et al.: 2004, Proc. Natl. Acad. Sci. U.S.A. 101, 9381-9386.
42. Laakkonen, P., Porkka, K., Hoffman, J. A. and Ruoslahti, E.: 2002, Nat. Med. 8, 751-755.
43. Ladner, R. C., Sato, A. K., Gorzelany, J. and de Souza, M.: 2004, Drug Discov. Today 9, 525-529.
44. Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierski, W. M. and Knapp, R. J.: 1991, Nature 354, 82-84.
45. Landon, L. A. and Deutscher, S. L.: 2003. J. Cell Biochem. 90, 509-517.
46. Levene, A. P., Singh, G. and Palmieri, C.: 2005, J. R. Soc. Med. 98, 146-152.
47. Lin, M. Z., Teitell, M. A. and Schiller, G. J.: 2005, Clin. Cancer Res. 11, 129-138.
48. Liu, L., Anderson, W. F., Beart, R. W., Gordon, E. M. and Hall, F. L.: 2000, J. Virol. 74, 5320-5328.
49. Liu, Y.: 2005, Cancer Lett. In press, Corrected Proof.
50. Matthews, T., Salgo, M., Greenberg, M., et al.: 2004, Nat. Rev. Drug Discov. 3, 215-225.
51. Miljanich, G. P.: 2004, Curr. Med. Chem. 11, 3029-3040.
52. Mori, T.: 2004, Curr. Pharm. Des. 10, 2335-2343.
53. Nielsen, L. L., Young, A. A. and Parkes, D. G.: 2004, Regul. Pept. 117, 77 .
54. Nilsson, F., Tarli, L., Viti, F. and Neri, D.: 2000, Adv. Drug Deliv. Rev. 43, 165-196.
55. Nixon, A. E.: 2002, Curr. Pharm. Biotechnol. 3, 1-12.
56. Oku, N., Asai, T., Watanabe, K., et al.: 2002, Oncogene 21, 2662-2669.
57. Pasqualini, R., Koivunen, E., Kain, R., et al.: 2000, Cancer Res. 60, 722-727.
58. Pasqualini, R. and Ruoslahti, E.: 1996, Nature 380, 364-366.
59. Patch, J. A. and Barron, A. E.: 2002, Curr. Opin. Chem. Biol. 6, 872-877.
60. Perea, S. E., Reyes, O., Puchades, Y., et al.: 2004, Cancer Res. 64, 7127-7129.
61. Petrenko, V. A. and Smith, G. P.: 2000, Protein Eng. 13, 589-592.
62. Rafii, S., Avecilla, S. T. and Jin, D. K.: 2003, Cancer Cell. 4, 331-333.
63. Reilly, R. M., Sandhu, J., Alvarez-Diez, T. M., et al.: 1995, Clin. Pharmacokinet. 28, 126-142.
64. Ritchie, B. C.: 2003, Transfus Apher. Sci. 29, 259-267.
65. Rodi, D. J. and Makowski, L.: 1999, Curr. Opin. Biotechnol. 10, 87-93.
66. Rodi, D. J., Mandava, S. and Makowski, L.: 2004, Bioinformatics 20, 3481-3489.
67. Rodi, D. J., Soares, A. S. and Makowski, L.: 2002, J. Mol. Biol. 322, 1039-1052.
68. Roges, O. A., Baron, M. and Philis-Tsimikas, A.: 2005, Expert. Opin. Investig. Drugs 14, 705-727.
69. Romanov, V. I.: 2003, Curr. Cancer Drug Targets 3, 119-129.
70. Rosenberg, A., Griffin, K., Studier, W., et al.: 1996, InNovations 6, 1-6.
71. Ruoslahti, E.: 2004, Biochem. Soc. Trans. 32, 397-402.
72. Russel, M., Lowman, H. B. and Clackson, T.: 2004, in T. Clackson and H. B. Lowman (eds.), Phage Display-A Practical Approach, Oxford University Press, New York, pp. 1-26.
73. Schumacher, T. N., Mayr, L. M., Minor, D. L. Jr., Milhollen, M. A., Burgess, M. W. and Kim, P. S.: 1996, Science 271, 1854-1857.
74. Scott, J. K.: 2001, in Barbas III, C. F. et al. (eds.), Phage Display: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 4.1-4.13.
75. Shadidi, M. and Sioud, M.: 2004, Methods Mol. Biol. 252, 569-580.
76. Smith, G. P.: 1985, Science 228, 1315-1317.
77. Stern, M. and Herrmann, R.: 2005, Crit. Rev. Oncol. Hematol. 54, 11-29.
78. Su, J.-L., Lai, K.-P., Chen, C.-A., et al.: 2005, Cancer Res. 65, 4827-4835.
79. Sullivan, D. C. and Ferrari, M.: 2004, Mol. Imaging 2004(3), 364-369.
80. Szardenings, M.: 2003, J. Recept. Signal Transduct. Res. 23, 307-349.
81. Tian, F., Tsao, M. L. and Schultz, P. G.: 2004, J. Am. Chem. Soc. 126, 15,962-15,963.
82. Wark, P. A.: 2002, IDrugs 5, 586-589.
83. Wiesehan, K., Buder, K., Linke, R. P., et al.: 2003, Chembiochem. 4, 748-753.
84. Wiesehan, K. and Willbold, D.: 2003, Chembiochem. 4, 811-815.
85. Winquist, R. J., Pan, J. Q. and Gribkoff, V. K.: 2005, Biochem. Pharmacol. 70, 489-499.
86. Xie, J. and Schultz, P. G.: 2005, Methods 36, 227-238.
87. Yao, V. J., Ozawa, M. G., Trepel, M., Arap, W., McDonald, D. M. and Pasqualini, R.: 2005, Am. J. Pathol. 166, 625-636.
88. Zitzmann, S., Mier, W., Schad, A., et al.: 2005, Clin. Cancer Res. 11, 139-146.
89. Zurita, A. J., Arap, W. and Pasqualini, R.: 2003, J. Control Release 91, 183-186.
90. Zurita, A. J., Troncoso, P., Cardo-Vila, M., et al.: 2004, Cancer Res. 64, 435-439.